Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumors × futuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Paclitaxel 11 Gemcitabine 9 Carboplatin 8 atezolizumab 6 Bevacizumab 6 navitoclax 4 liposomal doxorubicin 4 Irinotecan 4 Erlotinib Hydrochloride 4 Cetuximab 4 Sunitinib 3 Oxaliplatin 3 Leucovorin 3 Injections 3 Fluorouracil 3 Docetaxel 3 Cyclophosphamide 3 tocilizumab 2 tislelizumab 2 temsirolimus 2 ridaforolimus 2 plocabulin 2 pembrolizumab 2 pazopanib 2 olaparib 2 linifanib 2 fludarabine 2 envafolimab 2 darinaparsin 2 brigimadlin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01955473 2017-08-23

Japanese Phase 1 Trial of Sym004 in Solid Tumors

Merck KGaA, Darmstadt, Germany

Phase 1 Completed

51 enrolled 49 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡